JP2021517810A5 - - Google Patents
Info
- Publication number
- JP2021517810A5 JP2021517810A5 JP2020548676A JP2020548676A JP2021517810A5 JP 2021517810 A5 JP2021517810 A5 JP 2021517810A5 JP 2020548676 A JP2020548676 A JP 2020548676A JP 2020548676 A JP2020548676 A JP 2020548676A JP 2021517810 A5 JP2021517810 A5 JP 2021517810A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- cell
- cells
- binds
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023171939A JP7853938B2 (ja) | 2018-03-12 | 2023-10-03 | 養子免疫療法における腫瘍自己抗原の使用のための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862641541P | 2018-03-12 | 2018-03-12 | |
| US62/641,541 | 2018-03-12 | ||
| PCT/US2019/021827 WO2019178081A1 (en) | 2018-03-12 | 2019-03-12 | Methods and compositions for use of tumor self-antigens in adoptive immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171939A Division JP7853938B2 (ja) | 2018-03-12 | 2023-10-03 | 養子免疫療法における腫瘍自己抗原の使用のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021517810A JP2021517810A (ja) | 2021-07-29 |
| JP2021517810A5 true JP2021517810A5 (https=) | 2022-03-23 |
Family
ID=67908079
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020548676A Pending JP2021517810A (ja) | 2018-03-12 | 2019-03-12 | 養子免疫療法における腫瘍自己抗原の使用のための方法および組成物 |
| JP2023171939A Active JP7853938B2 (ja) | 2018-03-12 | 2023-10-03 | 養子免疫療法における腫瘍自己抗原の使用のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023171939A Active JP7853938B2 (ja) | 2018-03-12 | 2023-10-03 | 養子免疫療法における腫瘍自己抗原の使用のための方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12357694B2 (https=) |
| EP (2) | EP4197552A1 (https=) |
| JP (2) | JP2021517810A (https=) |
| AU (1) | AU2019234576B2 (https=) |
| CA (1) | CA3101310A1 (https=) |
| WO (1) | WO2019178081A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013059740A1 (en) | 2011-10-21 | 2013-04-25 | Foundation Medicine, Inc. | Novel alk and ntrk1 fusion molecules and uses thereof |
| US11230589B2 (en) | 2012-11-05 | 2022-01-25 | Foundation Medicine, Inc. | Fusion molecules and uses thereof |
| US11965892B2 (en) | 2017-02-12 | 2024-04-23 | Biontech Us Inc. | HLA-based methods and compositions and uses thereof |
| KR20240091046A (ko) * | 2018-12-21 | 2024-06-21 | 바이오엔테크 유에스 인크. | Hla 클래스 ii-특이적 에피토프 예측 및 cd4+ t 세포 특징화를 위한 방법 및 시스템 |
| EP4359570A4 (en) | 2021-06-25 | 2025-04-30 | Foundation Medicine, Inc. | METHODS OF USING SOMATIC HLA-I LOH TO PREDICT RESPONSE IN IMMUNE CHECKPOINT INHIBITOR-TREATED PATIENTS WITH LUNG CANCER |
| CN115636874A (zh) * | 2021-07-19 | 2023-01-24 | 武汉市朗典精医生物科技有限公司 | 制备神经肽y（npy）抗体及建立检测npy方法 |
| US20240352130A1 (en) * | 2021-08-24 | 2024-10-24 | The Children's Hospital Of Philadelphia | Peptide-centric chimeric antigen receptors to cancer self-peptides |
| EP4399710A2 (en) * | 2021-09-10 | 2024-07-17 | Immunoscape Pte. Ltd. | Systems and methods for the identification of target-specific t cells and their receptor sequences using machine learning |
| WO2023235882A2 (en) * | 2022-06-03 | 2023-12-07 | Fred Hutchinson Cancer Center | Immunotherapy targeting egfr antigens |
| WO2024178354A2 (en) * | 2023-02-24 | 2024-08-29 | The Children's Hospital Of Philadelphia | Improved phox2b pc-car generation based on structure and saturation mutagenesis |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7109030B2 (en) | 2000-03-31 | 2006-09-19 | Nuvelo, Inc. | Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| US7919467B2 (en) * | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| AU2003218601A1 (en) | 2002-04-08 | 2003-10-27 | The University Of Hong Kong | Phox2b polymorphisms as hirschsprung's disease diagnostic markers and methods based thereon |
| WO2004007770A2 (en) | 2002-07-10 | 2004-01-22 | Oncotherapy Science, Inc. | Method for diagnosis of intestinal-type gastric tumors |
| EP1549676A1 (en) | 2002-09-30 | 2005-07-06 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human myeloid leukemia |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| CN104066746B (zh) * | 2011-10-28 | 2017-12-05 | 肿瘤疗法科学股份有限公司 | Topk肽及包含它们的疫苗 |
| GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| US10335471B2 (en) | 2015-08-28 | 2019-07-02 | Immatics Biotechnologies Gmbh | Method for treating cancer with activated T cells |
| AU2017254477A1 (en) * | 2016-04-18 | 2018-11-01 | Jennifer G. ABELIN | Improved HLA epitope prediction |
| GB201609193D0 (en) * | 2016-05-25 | 2016-07-06 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers |
| US20180028634A1 (en) | 2016-07-29 | 2018-02-01 | Lan Bo Chen | Method for prolonging and enhancing anti-tumor vaccine response |
-
2019
- 2019-03-12 EP EP22209212.4A patent/EP4197552A1/en active Pending
- 2019-03-12 AU AU2019234576A patent/AU2019234576B2/en active Active
- 2019-03-12 JP JP2020548676A patent/JP2021517810A/ja active Pending
- 2019-03-12 CA CA3101310A patent/CA3101310A1/en active Pending
- 2019-03-12 US US16/979,138 patent/US12357694B2/en active Active
- 2019-03-12 EP EP19767951.7A patent/EP3765071A4/en not_active Withdrawn
- 2019-03-12 WO PCT/US2019/021827 patent/WO2019178081A1/en not_active Ceased
-
2023
- 2023-10-03 JP JP2023171939A patent/JP7853938B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021517810A5 (https=) | ||
| Bauer et al. | The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma | |
| JP2024041841A5 (https=) | ||
| JP2024099580A5 (https=) | ||
| Haen et al. | The repertoire of human tumor-associated epitopes—identification and selection of antigens and their application in clinical trials | |
| JP2019511214A5 (https=) | ||
| Zarling et al. | MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer | |
| CN113862292A (zh) | 嵌合抗原受体、组合物以及方法 | |
| JP2020516681A5 (https=) | ||
| RU2017137142A (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака | |
| JP2022081492A5 (https=) | ||
| JP2021514178A5 (https=) | ||
| Gray et al. | A phase I/randomized phase II study of GM. CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma | |
| JP2021535900A5 (https=) | ||
| JP2021528046A5 (https=) | ||
| Walters et al. | A novel DNA vaccine platform enhances neo-antigen-like T cell responses against WT1 to break tolerance and induce anti-tumor immunity | |
| JP2021522779A5 (https=) | ||
| JP2020530759A5 (https=) | ||
| JP2022502358A5 (https=) | ||
| Arriola et al. | TG4010: a vaccine with a therapeutic role in cancer | |
| Stephens et al. | Discovery of Therapeutic Antibodies Targeting Complex Multi-Spanning Membrane Proteins: AD Stephens et al. | |
| Lee et al. | Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis | |
| Kang et al. | Targeted coating with antigenic peptide renders tumor cells susceptible to CD8+ T cell-mediated killing | |
| Zeng et al. | An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response | |
| Zhao et al. | Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma |